Search research articles
Contact Us
Filters
Showing results (161-170 of 434) with videos related to
Page
of 44
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 16, 2013
Fibrillar amyloid correlates of preclinical cognitive decline
Cynthia M Stonnington, Kewei Chen, Wendy Lee, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 2, 2013
The neuropsychology of normal aging and preclinical Alzheimer's disease
Richard J Caselli, Dona E C Locke, Amylou C Dueck, et al.
Archives of Neurology
|
September 12, 2007
Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment
Richard J Caselli, Eric M Reiman, Dona E C Locke, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 11, 2010
The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core
William J Jagust, Dan Bandy, Kewei Chen, et al.
Journal of Alzheimer'S Disease : JAD
|
December 20, 2021
Studying APOE ɛ4 Allele Dose Effects with a Univariate Morphometry Biomarker
Gang Wang, Wenju Zhou, Deping Kong, et al.
EMBO Molecular Medicine
|
May 5, 2021
Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
Niklas Mattsson-Carlgren, Shorena Janelidze, Randall J Bateman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 16, 2025
Donanemab in preclinical Alzheimer's disease: Screening and baseline data from TRAILBLAZER-ALZ 3
Roy Yaari, Karen C Holdridge, Melissa Williamson, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
August 10, 2018
Adherence/Retention Alzheimer's Prevention Initiative Colombia Plan
Silvia Rios-Romenets, Natalia Acosta-Baena, Liliana Lopez, et al.
Neuroimage
|
February 22, 2012
Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: a cross-validation study using voxel-based multi-modal partial least squares
Kewei Chen, Napatkamon Ayutyanont, Jessica B S Langbaum, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 23, 2014
An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease
Jessica B Langbaum, Suzanne B Hendrix, Napatkamon Ayutyanont, et al.
Page
of 44
Search research articles
Search
Showing results (161-170 of 434) with videos related to
Sort By:
Page
of 44
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 16, 2013
Fibrillar amyloid correlates of preclinical cognitive decline
Cynthia M Stonnington, Kewei Chen, Wendy Lee, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 2, 2013
The neuropsychology of normal aging and preclinical Alzheimer's disease
Richard J Caselli, Dona E C Locke, Amylou C Dueck, et al.
Archives of Neurology
|
September 12, 2007
Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment
Richard J Caselli, Eric M Reiman, Dona E C Locke, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 11, 2010
The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core
William J Jagust, Dan Bandy, Kewei Chen, et al.
Journal of Alzheimer'S Disease : JAD
|
December 20, 2021
Studying APOE ɛ4 Allele Dose Effects with a Univariate Morphometry Biomarker
Gang Wang, Wenju Zhou, Deping Kong, et al.
EMBO Molecular Medicine
|
May 5, 2021
Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
Niklas Mattsson-Carlgren, Shorena Janelidze, Randall J Bateman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 16, 2025
Donanemab in preclinical Alzheimer's disease: Screening and baseline data from TRAILBLAZER-ALZ 3
Roy Yaari, Karen C Holdridge, Melissa Williamson, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
August 10, 2018
Adherence/Retention Alzheimer's Prevention Initiative Colombia Plan
Silvia Rios-Romenets, Natalia Acosta-Baena, Liliana Lopez, et al.
Neuroimage
|
February 22, 2012
Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: a cross-validation study using voxel-based multi-modal partial least squares
Kewei Chen, Napatkamon Ayutyanont, Jessica B S Langbaum, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 23, 2014
An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease
Jessica B Langbaum, Suzanne B Hendrix, Napatkamon Ayutyanont, et al.
Page
of 44